Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J, Huang Z, Sun R, Tian Z, Wei H.
J Autoimmun. 2012 Feb;38(1):20-8. Epub 2011 Dec 18.
Related citations
Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
Bresson D, Fousteri G, Manenkova Y, Croft M, von Herrath M.
J Autoimmun. 2011 Dec;37(4):342-51. Epub 2011 Nov 6.
The recent rise in the frequency of type 1 diabetes: who pulled the trigger?
Hasham A, Tomer Y.
J Autoimmun. 2011 Aug;37(1):1-2. No abstract available.
IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
Li CR, Deiro MF, Godebu E, Bradley LM.
J Autoimmun. 2011 Nov;37(3):217-27. Epub 2011 Jul 13.
Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice.
Kaminitz A, Yolcu ES, Stein J, Yaniv I, Shirwan H, Askenasy N.
J Autoimmun. 2011 Aug;37(1):39-47. Epub 2011 Apr 15.
Specific maternal microchimeric T cells targeting fetal antigens in β cells predispose to auto-immune diabetes in the child.
Roy E, Leduc M, Guegan S, Rachdi L, Kluger N, Scharfmann R, Aractingi S, Khosrotehrani K.
J Autoimmun. 2011 May;36(3-4):253-62. Epub 2011 Mar 17.
Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.
Ziegler AG, Pflueger M, Winkler C, Achenbach P, Akolkar B, Krischer JP, Bonifacio E.
J Autoimmun. 2011 Aug;37(1):3-7. Epub 2011 Mar 3.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on